Syrrx Inc.
This article was originally published in Start Up
Executive Summary
In less than a year, Syrrx Inc. has raised $80 million of initial funding to build a business in structural proteomics--the process of generating protein structures from genetic information. The company wants to determine high-resolution protein structures at a historically unprecedented rate, and thereby speed the identification and optimization of rationally designed therapeutic small molecules.